L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]-

Request For Quotation
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Suppliers list
Company Name: Hangzhou Peptidego Biotech Co.,Ltd.  
Tel: 0571-87213919 15967184799
Email: Eric@peptidego.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Nanchang Tianzhen Biotechnology Co., Ltd  
Tel: 13758194781 13173652190
Email: 522013271@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: YantaiBio  
Tel: 13758194781; 13758194781
Email: 764619768@qq.com

L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- manufacturers

  • MIP-1095
  • MIP-1095 pictures
  • $1980.00
  • 2026-05-11
  • CAS:949575-22-8
  • Purity:
  • Supply Ability: 10g
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Basic information
Product Name:L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]-
Synonyms:L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]-;MIP 1095;MIP1095;MIP-1095;MIP1095,MIP 1095
CAS:949575-22-8
MF:C19H25IN4O8
MW:564.33
EINECS:
Product Categories:
Mol File:949575-22-8.mol
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Structure
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Chemical Properties
Boiling point 811.3±65.0 °C(Predicted)
density 1.687±0.06 g/cm3(Predicted)
pka3.78±0.10(Predicted)
Safety Information
MSDS Information
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Usage And Synthesis
UsesMIP-1095 potently inhibits the glutamate carboxypeptidase activity of PSMA (Ki =0.24 nM)[1].
References[1] Shawn M Hillier, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res. 2009 Sep 1;69(17):6932-40. DOI:10.1158/0008-5472.CAN-09-1682
L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]- Preparation Products And Raw materials
Tag:L-Glutamic acid, N-[[[(1S)-1-carboxy-5-[[[(4-iodophenyl)amino]carbonyl]amino]pentyl]amino]carbonyl]-(949575-22-8) Related Product Information
Pelgifatamab (2R,3R)-3,5,7-Trihydroxy-2-[(2S,3S)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydrobenzo[1,4]dioxin-6-yl]-4-chromanone PSMA-11 Anti-PSMA Antibody HYNIC-iPSMA TFA (S)-5-tert-butoxy-4-(3-((S)-1,5-di-tert-butoxy-1,5-dioxopentan-2-yl)ureido)-5-oxopentanoic acid